Showing 45 results for Diabet
Habibeh Sadat Mosavi , Mohammad Taher Hojjati , Khodaberdi Kalavi,
Volume 18, Issue 5 (9-2024)
Abstract
Background: Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia, disturbed lipid metabolism, and cardiovascular disease (CVD). Poor glycemic control results in lipid and lipoprotein abnormalities, suggesting that dyslipidemia is secondary to insulin resistance or factors closely related to insulin resistance. Glaciated hemoglobin (HbA1c) is a routinely used marker for long-term glycemic control. This form of hemoglobin is chemically processed through post-translational glycosylation that reflects the plasma glucose concentration during the last two to three months.
Methods: This cross-sectional study was conducted on blood samples from 592 cases referred to Dezyani Specialty Clinic, affiliated with the Golestan University of Medical Sciences. In patients with diabetes mellitus (DM) and non-diabetic individuals, hemoglobin A1c (HbA1c), total cholesterol (T-chol), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured.
Results: In the study, there were 460 female participants (76.9%) and 132 male participants (23.1%). Among them, 403 (67.4%) were diabetic patients, and 193 (32.4%) were non-diabetic. HbA1c levels were significantly lower in younger individuals than in middle-aged participants (p=0.000). No significant difference was found between middle-aged and older individuals (p>0.121). LDL levels were significantly lower in the young group than in the middle-aged group (p<0.001). Total cholesterol (TC) was also significantly lower in the young group compared to middle-aged and older groups (p<0.001).
Conclusion: HbA1c can be a helpful lipid and glycemic control marker in diabetes.
Mahendran Kanumuru, Sridevi Nutakki ,
Volume 18, Issue 6 (11-2024)
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a non-communicable disease, manifesting hyperinsulinemia, insulin resistance, hyperglycemia, and low-grade chronic inflammation associated with various micro and macrovascular complications. The present study aimed to estimate vitamin D (Vit D) levels, total antioxidant capacity, and malondialdehyde (MDA) levels in T2DM patients compared with healthy individuals. In addition, we assessed Vit D, total antioxidant capacity, and MDA levels in patients with T2DM and their association with HbA1c, insulin resistance and lipid profile parameters.
Methods: Seventy patients with T2DM aged 35 to 50 years were selected and 70 healthy age-matched subjects were selected as controls. Serum Vit D and insulin were estimated by the enzyme-linked immunosorbent assay (ELISA). Glycosylated hemoglobin (HbA1C) was assessed by high-performance liquid chromatography (HPLC) method and other routine lipid profile investigations were carried out using a Beckman Coulter fully automated analyzer.
Results: Vitamin D levels significantly decreased in T2DM patients. HbA1C and insulin resistance values are significantly increased in type 2 diabetic patients. Vitamin D levels negatively correlated with MDA, insulin resistance, and HbA1c, while positively correlated with total antioxidant capacity. Nevertheless, there is no significant correlation between lipid profile parameters.
Conclusion: Vitamin D deficiency may be one of the vital risk factors responsible for increased oxidative stress in patients with T2DM. Regular monitoring and supplementation of Vit D are beneficial for the reduction of oxidative stress and vascular complications in these patients.
Sharabeh Hezarkhani , Khosro Ghojoghi , Sara Hosseinzadeh , Naser Behnampour , Farshid Fathabadi , Zahra Hesari , Hamid Reza Joshaghani ,
Volume 18, Issue 6 (11-2024)
Abstract
Background: Leptin and adiponectin, two members of the adipokine family, play roles in increasing lipid metabolism and inhibiting lipogenesis. Reduced levels of these cytokines are associated with obesity and insulin resistance. This study aimed to determine the serum levels of leptin and adiponectin in type-2 diabetic patients with and without metabolic syndrome compared to a control group.
Methods: Three groups of individuals participated in this study: 47 type-2 diabetic patients with metabolic syndrome (DM+MetS), 25 type-2 diabetic patients without metabolic syndrome (DM-MetS), and 40 individuals with no history of diabetes or metabolic syndrome (Control group). Fasting blood samples were collected, and serum levels of fasting blood sugar, cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol were measured using the enzymatic method. Blood pressure, height, and weight were recorded using stadiometers, while leptin and adiponectin levels were determined via enzyme-linked immunosorbent assay.
Results: A significant difference was observed between the DM+MetS group and the DM-MetS group in serum leptin (p = 0.004) and adiponectin (p < 0.001) levels. In patients with type-2 diabetes and metabolic syndrome, serum leptin (p = 0.530) and adiponectin (p < 0.001) levels were lower compared to the control group.
Conclusion: A decrease in the serum levels of key adipokines, such as leptin and adiponectin, in type-2 diabetic patients may serve as a predictor of metabolic syndrome.
Dr Hamid Malekshahiniya, Dr Roohollah Mohammadi Mirzaei, Dr Halimeh Vahdatpoor,
Volume 19, Issue 1 (4-2025)
Abstract
The aim of this study is to investigate the effect of 6 weeks of intermittent exercise on the serum level of nitric oxide, insulin resistance and some lipid profiles in male diabetic rats. Materials and methods: In this experimental study, 60 anesthetized rats (200±20) were randomly divided into 6 groups of 10:1-control-healthy, 2-sham, 3-periodic, 4-periodic+saline, 5-diabetic and 6- Diabetes + interval training were divided. Diabetes was induced by intraperitoneal injection of nicotinamide-streptozotocin. The subjects trained on the treadmill for 6 weeks, 5 sessions a week. 48 hours after the last training session, slaughter was performed and then glucose, insulin, nitric oxide, LDL, HDL, TG and cholesterol levels were measured. One-way variance test and Tukey's post hoc test were used for data analysis(p<0.05). Results: Induction of diabetes increased glucose and insulin resistance and decreased insulin and nitric oxide in the diabetic group compared to the control group. After 6 weeks of intermittent training in the diabetes group + intermittent training, the amount of glucose and insulin resistance decreased compared to the diabetes group, but the nitric oxide level increased compared to the diabetes group. But it had no effect on insulin levels. Also, 6 weeks of intermittent training had no significant effect on the amount of lipid factors in different groups(p<0.05). Conclusion: According to the results of the present study, it seems that interval training can create a protective effect against vascular diseases in diabetic patients by reducing insulin resistance and increasing nitric oxide, and as a result, improving vascular function.
Parisa Hasanein, Fahime Javadi Hedaiat Abad, Musa Bohlooli, Mostafa Khajeh, Sedigheh Esmaielzadeh Bahabadi, Neda Poormolaei,
Volume 19, Issue 1 (4-2025)
Abstract
Introduction: DNA Glycation damages DNA by inducing breaks of strands, mutations, and finally changes in gene expression, which is assumed as a main factor in pathogenesis of diabetes and its complications. Therefore, antiglycation agents have been focused recently for preventing and alleviating diabetes complications. According to the reported antidiabetic effects of Tamarix aphylla (T. aphylla) leaves extract, this study was aimed to determine the effect of T. aphylla on glucose-mediated DNA glycation for the first time.
Methods: DNA incubated with glucose for 4 weeks and the inhibitory or fascilitatory effects of T. aphylla on DNA structural changes were studied by various techniques. These techniques were included UV–Vis, fluorescence spectroscopy, circular dichroism (CD) and agarose gel electrophoresis.
Results: The findings of UV–Vis and fluorescence spectroscopy showed that T. aphylla decreased the DNA-AGE (advanced glycation end products) formation. Based on the CD and agarose gel electrophoresis results, the structural changes of glycated DNA was decreased in the presence of T. aphylla.
Conclusion: Thus T. aphylla has beneficial effects against DNA glycation and could be a promising agent for ameliorate the adverse effects of glycation in the presence of glucose and conditions of raised blood glucose after confirming in further studies.
